Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $8.4M | 3 | 99.8% |
| Travel and Lodging | $7,955 | 6 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,000 | 2 | 0.1% |
| Grant | $1,000 | 1 | 0.0% |
| Food and Beverage | $871.58 | 8 | 0.0% |
| Education | $10.31 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Asklepios Biopharmaceutical Inc. | $7.4M | 2 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $1.0M | 1 | $0 (2022) |
| GENZYME CORPORATION | $13,898 | 11 | $0 (2018) |
| VERTEX PHARMACEUTICALS INCORPORATED | $1,216 | 2 | $0 (2017) |
| PFIZER INC. | $410.21 | 1 | $0 (2017) |
| Amicus Therapeutics, Inc. | $154.75 | 1 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2018) |
| Ultragenyx Pharmaceutical Inc. | $22.54 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3.4M | 1 | Asklepios Biopharmaceutical Inc. ($3.4M) |
| 2023 | $3.9M | 1 | Asklepios Biopharmaceutical Inc. ($3.9M) |
| 2022 | $1.0M | 2 | Bayer HealthCare Pharmaceuticals Inc. ($1.0M) |
| 2021 | $154.75 | 1 | Amicus Therapeutics, Inc. ($154.75) |
| 2020 | $2.49 | 3 | Travere Therapeutics, Inc. ($2.49) |
| 2018 | $12,171 | 8 | GENZYME CORPORATION ($12,039) |
| 2017 | $3,486 | 8 | GENZYME CORPORATION ($1,860) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Asklepios Biopharmaceutical Inc. | — | Acquisitions | Cash or cash equivalent | $3,431,676.01 | General |
| 12/29/2023 | Asklepios Biopharmaceutical Inc. | — | Acquisitions | Cash or cash equivalent | $3,944,327.67 | General |
| 12/29/2022 | Bayer HealthCare Pharmaceuticals Inc. | — | Acquisitions | Cash or cash equivalent | $1,005,900.56 | General |
| 05/17/2022 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $22.54 | General |
| 12/06/2021 | Amicus Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $154.75 | General |
| 03/04/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 03/04/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 03/04/2020 | Travere Therapeutics, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 11/28/2018 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 11/16/2018 | GENZYME CORPORATION | LUMIZYME (Drug) | Travel and Lodging | In-kind items and services | $5,894.67 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 11/16/2018 | GENZYME CORPORATION | LUMIZYME (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 11/16/2018 | GENZYME CORPORATION | LUMIZYME (Drug) | Travel and Lodging | In-kind items and services | $579.87 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 11/16/2018 | GENZYME CORPORATION | LUMIZYME (Drug) | Food and Beverage | In-kind items and services | $337.35 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 11/16/2018 | GENZYME CORPORATION | LUMIZYME (Drug) | Travel and Lodging | In-kind items and services | $326.07 | General |
| Category: RARE DISEASE GENETICS | ||||||
| 09/06/2018 | Retrophin, Inc. | (820) Cholbam (Drug) | Education | In-kind items and services | $7.82 | General |
| Category: Hepatology | ||||||
| 03/12/2018 | GENZYME CORPORATION | DISEASE STATE (Drug) | Food and Beverage | In-kind items and services | $100.62 | General |
| 10/07/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Grant | Cash or cash equivalent | $1,000.00 | General |
| 10/07/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $381.00 | General |
| 10/07/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | Cash or cash equivalent | $363.04 | General |
| 10/07/2017 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Food and Beverage | In-kind items and services | $94.87 | General |
| 10/06/2017 | VERTEX PHARMACEUTICALS INCORPORATED | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| 08/11/2017 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $15.67 | General |
| 05/09/2017 | PFIZER INC. | — | Travel and Lodging | In-kind items and services | $410.21 | General |
| 02/15/2017 | GENZYME CORPORATION | DISEASE STATE (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 14 | $4,816 | $1,331 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 14 | $4,816 | $1,331 | 27.6% |
About Dwight Koeberl
Dwight Koeberl is a Pediatrics healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023192184.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dwight Koeberl has received a total of $8.4M in payments from pharmaceutical and medical device companies, with $3.4M received in 2024. These payments were reported across 24 transactions from 10 companies. The most common payment nature is "Acquisitions" ($8.4M).
As a Medicare-enrolled provider, Koeberl has provided services to 11 Medicare beneficiaries, totaling 14 services with total Medicare billing of $1,331. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Location Durham, NC
- Active Since 10/25/2006
- Last Updated 07/10/2023
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1023192184
Products in Payments
- LUMIZYME (Drug) $11,938
- NO PRODUCT DISCUSSED (Drug) $1,839
- Strensiq (Drug) $125.00
- DISEASE STATE (Drug) $121.40
- (820) Cholbam (Drug) $10.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Durham
Priya Kishnani
Pediatrics — Payments: $5.9M
John Sleasman, Md, MD
Pediatrics — Payments: $322,883
Edward Smith, Md, MD
Pediatrics — Payments: $195,857
Dr. Muhammad Zafar, M.d, M.D
Pediatrics — Payments: $158,957
Jennifer Li, Md, MD
Pediatrics — Payments: $55,856
Sarah Armstrong, Md, MD
Pediatrics — Payments: $46,142